Skip to main content
. 2020 Jan 29;132(3):79–89. doi: 10.1007/s00508-019-01599-4

Fig. 6.

Fig. 6

Percentage (%) of cases treated with glycoprotein IIb/IIIa receptor blockers (GP-blocker) per PCI in Austria (AU; 1997–2017) and in Switzerland (CH; 1997–2009) and percentage (%) of cases treated with direct thrombin inhibitors (AU-TI) during PCI in Austria (AU-TI; 2005–2017). [113]. (Source: [18, pp 22])